SEARCH

SEARCH BY CITATION

Keywords:

  • Ecto-alkaline phosphatase;
  • P1 antagonist-sensitive ATP response;
  • ATP;
  • AMP;
  • PPADS;
  • levamisole;
  • β-glycerophosphate;
  • NG108-15 cells
  • We previously demonstrated that extracellular adenine nucleotides induced cyclic AMP elevation through local adenosine production at the membrane surface and subsequent activation of adenosine A2A receptors in NG108-15 cells. Furthermore, the adenosine formation was found to be mediated by an ecto-enzyme distinct from the ecto-5′-nucleotidase (CD73). In this study, we investigated the properties of the ecto-AMP phosphohydrolase activity in NG108-15 cells.

  • NG108-15 cells hydrolyzed AMP to adenosine with the KM value of 18.8±2.2 μM and Vmax of 5.3±1.6 nmol min−1 106 cells−1. This activity was suppressed at pH 6.5, but markedly increased at pH 8.5.

  • The AMP hydrolysis was blocked by levamisole, an alkaline phosphatase (ALP) inhibitor. NG108-15 cells released orthophosphate from 2′- and 3′-AMP as well as from ribose-5-phosphate and β-glycerophosphate, indicating that NG108-15 cells express ecto-ALP.

  • The cyclic AMP accumulation induced by several adenine nucleotides was inhibited by levamisole, p-nitrophenylphosphate and β-glycerophosphate, with a parallel decrease in the extracellular adenosine formation.

  • Reverse transcriptase polymerase chain reaction analysis revealed that NG108-15 cells express mRNA for the tissue-nonspecific isozyme of ALP.

  • These results demonstrate that AMP phosphohydrolase activity in NG108-15 cells is due to ecto-ALP, and suggest that this enzyme plays an essential role for the P1 antagonist-sensitive ATP-induced cyclic AMP accumulation in NG108-15 cells.

British Journal of Pharmacology (2000) 131, 1667–1672; doi:10.1038/sj.bjp.0703750